AwardedUnited KingdomGoods£1
Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025)
- Published
- Published 29 August 2025
- Deadline
- Closed 10 March 2025
Overview
Contracts for the supply of vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme.
Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
The awarding of lots is not appropriate for this procurement.
Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.
Key details
- Country
- United Kingdom
- Status
- Awarded
- Category
- Goods
- Estimated value
- £1
- Procedure
- Open
- SME suitable
- No
- Published
- 29 August 2025
- Deadline
- Closed
Vaccines
Award outcome
- Awarded value
- £1
- Award date
- 6 August 2025
- Contract period
- 30 September 2025 → 30 September 2029
- GlaxoSmithKline UK Ltd - Vaccines
- Merck Sharpe & Dohme (UK) Limited
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
29 August 2025
Contracting authority
UK Health Security Agency
BuyerLondon, United Kingdom
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.